Viva Biotech Holdings

OTCPK:VBIZ.F Stock Report

Market Cap: US$242.6m

Viva Biotech Holdings Management

Management criteria checks 4/4

Viva Biotech Holdings' CEO is Chen Cheney Mao, appointed in Jul 2018, has a tenure of 6.33 years. total yearly compensation is CN¥2.39M, comprised of 60.8% salary and 39.2% bonuses, including company stock and options. directly owns 15.81% of the company’s shares, worth $38.35M. The average tenure of the management team and the board of directors is 3.6 years and 5.6 years respectively.

Key information

Chen Cheney Mao

Chief executive officer

CN¥2.4m

Total compensation

CEO salary percentage60.8%
CEO tenure6.3yrs
CEO ownership15.8%
Management average tenure3.6yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Chen Cheney Mao's remuneration changed compared to Viva Biotech Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥318k

Mar 31 2024n/an/a

-CN¥58m

Dec 31 2023CN¥2mCN¥1m

-CN¥116m

Sep 30 2023n/an/a

-CN¥276m

Jun 30 2023n/an/a

-CN¥436m

Mar 31 2023n/an/a

-CN¥482m

Dec 31 2022CN¥3mCN¥1m

-CN¥528m

Sep 30 2022n/an/a

-CN¥209m

Jun 30 2022n/an/a

CN¥111m

Mar 31 2022n/an/a

CN¥199m

Dec 31 2021CN¥2mCN¥1m

CN¥288m

Sep 30 2021n/an/a

CN¥258m

Jun 30 2021n/an/a

CN¥228m

Mar 31 2021n/an/a

-CN¥79m

Dec 31 2020CN¥1mCN¥957k

-CN¥387m

Sep 30 2020n/an/a

-CN¥349m

Jun 30 2020n/an/a

-CN¥311m

Mar 31 2020n/an/a

-CN¥23m

Dec 31 2019CN¥1mCN¥954k

CN¥266m

Compensation vs Market: Chen Cheney's total compensation ($USD330.77K) is below average for companies of similar size in the US market ($USD1.46M).

Compensation vs Earnings: Chen Cheney's compensation has been consistent with company performance over the past year.


CEO

Chen Cheney Mao (62 yo)

6.3yrs

Tenure

CN¥2,394,000

Compensation

Dr. Chen Cheney Mao, Ph D has been Chairman of Viva Biotech Holdings since July 03, 2018 and served as Chief Executive Officer of Viva Biotech Holdings since July 03, 2018 until December 1, 2023. He Founde...


Leadership Team

NamePositionTenureCompensationOwnership
Chen Cheney Mao
Chairman & CEO6.3yrsCN¥2.39m15.81%
$ 38.3m
Ying Wu
Executive VP & Executive Director6.3yrsCN¥2.68m0.81%
$ 2.0m
Delin Ren
Executive Directorless than a yearCN¥3.68m0.70%
$ 1.7m
Wei Xiong
Chief Financial Officerless than a yearno datano data
Xueheng Cheng
Chief Technology Officer5.3yrsno datano data
Zhixiong Ye
Chief Scientific Officer6.3yrsno datano data
Han Dai
Chief Innovation Officer & Head of Viva BioInnovatorno datano datano data
Jianhua Cai
Senior Vice Presidentno datano datano data
Jianguo Ma
Senior VP & President of Shanghai Langhua Pharmaceuticalno datano datano data
Xianyong Bu
CBO & EVP of Viva Biotech (Shanghai)no datano datano data
Rongqiang Liu
Senior Vice President2yrsno datano data
Derek Ren
CEO of Viva Biotech (Shanghai) Ltd.less than a yearno datano data

3.6yrs

Average Tenure

61.5yo

Average Age

Experienced Management: VBIZ.F's management team is considered experienced (3.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Chen Cheney Mao
Chairman & CEO6.3yrsCN¥2.39m15.81%
$ 38.3m
Ying Wu
Executive VP & Executive Director15.2yrsCN¥2.68m0.81%
$ 2.0m
Delin Ren
Executive Director6.3yrsCN¥3.68m0.70%
$ 1.7m
Haiguang Wang
Independent Non-Executive Director5.6yrsCN¥225.00kno data
Lei Fu
Independent Non-Executive Director5.6yrsCN¥225.00kno data
Xiangrong Li
Independent Non-Executive Director5.6yrsCN¥225.00kno data
Yuting Wu
Non-Executive Director2yrsCN¥225.00kno data
Hui Wang
Non-Executive Directorless than a yearno data4.01%
$ 9.7m

5.6yrs

Average Tenure

61yo

Average Age

Experienced Board: VBIZ.F's board of directors are considered experienced (5.6 years average tenure).